Health

Novo Nordisk has been on the hunt for differentiated obesity drugs that could complement its blockbuster GLP-1 agonist, Wegovy. It’s...

By MIKE MAGEE “The recently announced limitation from the NIH on grants is an example that will significantly reduce essential...

For the first time, traditional drug spending has exceeded specialty drug spending, largely due to the demand for GLP-1s, according...

By MATT McCORD American manufacturing is making a comeback. Driven by tariffs, supply chain instability, and shifting economic priorities, companies...

By KIM BELLARD News flash: America is not a very happy place these days. No, I’m not talking about the...

23andMe CEO Anne Wojcicki has been trying to take the DNA testing company private this past year, making clear along...

An ultra-rare kidney disease that can become life-threatening now has its first FDA-approved therapy. The affirmative regulatory decision is the...

Companies all across the healthcare industry are looking to scale their AI abilities, often striking multi-year collaborations with Big Tech...

By MATTHEW HOLT The big news in the comeback of digital health is that Hinge Health filed its S1 and...

Evvy, a women’s health company, is now offering fertility insights through its vaginal microbiome test, the company announced on Tuesday....